Objectives: Attendees will be able to understand the vascular mechanisms behind filler-related blindness, identify high-risk injection areas, and implement safe injection and rescue protocols to minimize complications—ensuring better patient outcomes.
Introduction: Filler-induced blindness is a rare but devastating complication in aesthetic medicine. It primarily arises from vascular occlusion in high-risk facial zones. This session explores emerging data, updated protocols, and the supraorbital injection method to reduce the risk of permanent vision loss.
Materials / method: Evidence-based data from peer-reviewed case studies, the Aesthetic Surgery Journal’s 2024 review, and Dr. Treacy’s supraorbital technique form the basis of this analysis. Protocols include hyaluronidase injection strategies, real-time ocular assessment, and emergent management workflows.
Results: Clinicians using supraorbital hyaluronidase injections reported improved vision recovery rates, with some patients regaining near-normal sight. Early recognition and immediate intervention, including ocular assessments and hyaluronidase protocols, significantly reduced permanent blindness risk.
Conclusion: Filler-induced blindness remains a rare but critical emergency. Emphasizing proper anatomy, slow injection techniques, and an immediate rescue plan with supraorbital hyaluronidase is crucial. Advancements in management continue to improve outcomes for at-risk patients.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。